Scout | NCI R33 grants to develop and validate emerging cancer research technologies (clinical trial not allowed)

nofo

NCI R33 grants to develop and validate emerging cancer research technologies (clinical trial not allowed)

The National Cancer Institute is inviting R33 applications for exploratory projects that advance and technically validate new or emerging technologies for molecular and cellular cancer characterization, or for improved biospecimen handling and quality control. Proposals should address remaining feasibility gaps using preliminary data and focus on cancer-relevant use cases. Using existing techn…

Source

Agency: National Institutes of Health

Award

Total Funding: $5.9M

Award Ceiling: $300,000

Dates

Open Date: June 3, 2026

Close Date: November 10, 2026

Eligibility

government

industry:research

nonprofit

small_business

tribal

university

For profit organizations other than small businesses

Native American tribal governments (Federally recognized)

Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

Private institutions of higher education

State governments

Keywords

cancer technology

molecular analysis

biospecimen quality

technical validation

emerging methods

nci imat

r33 exploratory

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers